Autres langues

03/08 Bedrijfskalender van 3 tot 7 augustus 2026
03/08 TAGESVORSCHAU/Dienstag, 4. August 2026 (vorläufige Fassung)
03/08 Is everything under control?
03/08 Agenda de resultados empresariales del 3 al 7 de agosto de 2026
03/08 Calendario delle società: 3 - 7 agosto 2026
03/08 Unternehmenskalender vom 3. bis 7. August 2026
03/08 Morning meeting: ¿Todo bajo control?
03/08 Is Everything Under Control?
31/07 Amgen discloses data breach involving patient health information
31/07 Amgen Says Proprietary Data, Patient Health Info Were Exfiltrated in Cyber Incident
31/07 Amgen Finds No Material Impact From Cybersecurity Incident
31/07 Amgen discloses data breach, says patient information was stolen
31/07 WOCHENVORSCHAU/3. August bis 9. August 2026 (32. KW)
30/07 Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable Sept. 11 to Holders of Record Aug. 21
30/07 Amgen Inc. Announces 2026 Third Quarter Dividend, Payable on September 11, 2026
30/07 AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND
29/07 Amgen Receives Positive CHMP Opinion for Expanded Use of Repatha to Reduce Cardiovascular Risk in High-Risk Adults
29/07 Amgen : POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE
28/07 AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS
27/07 Sarepta names former Abbvie president as CEO as Ingram retires
27/07 China's Innocare says psoriasis oral drug shows 'consistent treatment effect' in late-stage trial
27/07 Protecting Antibody Innovations Beyond Composition Claims
24/07 Amgen submits new data to challenge FDA's proposal to withdraw Tavneos
24/07 WOCHENVORSCHAU/3. August bis 9. August 2026 (32. KW)
24/07 Unternehmenskalender vom 27. bis 31. Juli 2026
Aucun résultat pour cette recherche
🔇